Study of INCB123667 in Subjects With Advanced Solid Tumors
Incyte Corporation
Incyte Corporation
Myeloid Therapeutics
Novartis
Nurix Therapeutics, Inc.
Xencor, Inc.
Lyell Immunopharma, Inc.
Dana-Farber Cancer Institute
Theratechnologies
University of Washington
Exelixis
Carisma Therapeutics Inc
Light Chain Bioscience - Novimmune SA
Exelixis
Eli Lilly and Company
BioEclipse Therapeutics
Multitude Therapeutics Inc.
Canadian Cancer Trials Group
Xencor, Inc.
MacroGenics
AIDS Malignancy Consortium
Abramson Cancer Center at Penn Medicine
University of Maryland, Baltimore
University of Washington
Pfizer
Albert Einstein College of Medicine
University of Chicago
Wake Forest University Health Sciences
University of Washington
University of Louisville
University of Southern California
University of Arizona
Rutgers, The State University of New Jersey
City of Hope Medical Center
University of Washington
Indiana University
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University